BRD8 and breast carcinoma: The knockdown of TWIST1 or BRD8 or the blockade of PD-L1 activity can successfully reverse CD8+ T-cell exhaustion and reinvigorate CD8+ T cells, leading them to inhibit the growth of breast cancer cells.